ConvaTec Group PLC Director/PDMR Shareholding (5179C)
19 Octubre 2020 - 9:30AM
UK Regulatory
TIDMCTEC
RNS Number : 5179C
ConvaTec Group PLC
19 October 2020
19 October 2020
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
On 15 October 2020, Mr Rick Anderson, Non-Executive Director and
a PDMR, acquired 547 Shares at GBP1.8628 per share under the Scrip
Dividend Scheme. Mr Anderson's resulting shareholding is 209,137
Shares.
The attached notification, made in accordance with the
requirements of the EU Market Abuse Regulation, gives further
detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Rick Anderson
2 Reason for the notification
a) Position/Status Non-Executive Director
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
instrument, type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction Acquisition of Shares under Scrip Dividend Scheme
c) Price(s) and volume(s) Price(s) Volume(s)
GBP1.8628 547
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 15 October 2020
f) Place of the transaction Outside a trading venue
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations &
Corporate Communications, ConvaTec +44 (0)7826 447807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. Our vision, which
encompasses our purpose, is: Pioneering trusted medical solutions
to improve the lives we touch. Our products provide a range of
clinical and economic benefits including infection prevention,
protection of at-risk skin, improved patient outcomes and reduced
total cost of care. To learn more about ConvaTec, please visit
www.convatecgroup.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFLSIRLALII
(END) Dow Jones Newswires
October 19, 2020 10:30 ET (14:30 GMT)
Convatec (LSE:CTEC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Convatec (LSE:CTEC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024